A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Dravet Syndrome
Related studies linked through entity extraction aliases.
A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome
- Status
- TERMINATED
- Phase
- PHASE3
Turmeric as Treatment in Epilepsy
- Status
- WITHDRAWN
- Phase
- NA
A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy
- Status
- WITHDRAWN
- Phase
- N/A
Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE3
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population
- Status
- COMPLETED
- Phase
- N/A
GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
- Status
- TERMINATED
- Phase
- PHASE3
Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE3
Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)
- Status
- COMPLETED
- Phase
- PHASE3
A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)
- Status
- COMPLETED
- Phase
- PHASE2
Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Compassionate Use of Stiripentol in Dravet Syndrome
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A